Institute 3 (ticket)
Managing Psychiatrically Referred Youth With Autism: From Diagnosis to Treatment

This Institute provides psychiatrists, pediatricians, and other mental health professionals a practical and useful synthesis of the most recent research on the etiology, assessment, and treatment of autism spectrum disorder (ASD). Clinicians are frequently asked to evaluate social interaction and communication problems along with odd behaviors in children with emotional and behavioral difficulties. Although they may be able to recognize diagnostic symptoms of autism, they are uncertain about how to screen out comorbid psychiatric or medical disorders. The rapid expansion of research in autism provides additional information that has important clinical implications. This Institute provides a review of DSM-5 criteria, reviews diagnostic procedures, explores educational, psychotherapeutic, and behavioral interventions, and presents advances in diagnosis, assessment, neuroimaging, and genetic research. Participants learn to develop a realistic plan to help patients with ASD achieve optimum functioning and adaptive life skills, and to advocate for quality interventions for high-risk preschoolers.
Wednesday, October 22, 2014: 8:00 AM-4:00 PM
Chairs:
8:00 AM  
Introduction
8:15 AM  
3.1
An Unexpected Life: Helping Families to Transition Their Children With Autism Into Adulthood
Alice R. Mao, MD Baylor College of Medicine, Houston, TX
8:45 AM  
3.2
Diagnostic Assessment for Autism Spectrum Disorder
Bryan H. King, MD Children's Hospital, Seattle, WA
9:30 AM  
3.3
Psychiatric Comorbidity: Prevalence and Presentation
Gagan Joshi, MD Massachusetts General Hospital, Boston, MA
10:15 AM  
Break
10:30 AM  
3.4
Medical Comorbidity and Genetic Work-Up
Daniel Coury, MD Ohio State University College of Medicine, Columbus, OH
11:15 AM  
3.5
The Psychopharmacology of Autism Spectrum Disorder
Christopher J. McDougle, MD Harvard Medical School, Lexington, MA
12:00 PM  
Lunch (on your own)
1:15 PM  
3.6
Neuroimaging in Autism Spectrum Disorder
Antonio Hardan, MD Stanford University, Stanford, CA
2:00 PM  
3.7
Modularized and Targeted Treatments on Core Deficits for Children With Autism Spectrum Disorder
Connie Kasari, PhD University of California, Los Angeles, Los Angeles, CA
2:45 PM  
Break
3:00 PM  
3.8
New Drug Targets and Potential Role of Pharmacogenetics in Autism Spectrum Disorder
James T. McCracken, MD UCLA Semel Institute for Neuroscience, Los Angeles, CA
3:45 PM  
Comments and Questions & Answers

Sponsored by the AACAP Autism and Intellectual Disability Committee

See more of: Institute
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.